HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myocardial Ischemic Burden and Differences in Prognosis Among Patients With and Without Diabetes: Results From the Multicenter International REFINE SPECT Registry.

AbstractOBJECTIVE:
Prevalence and prognostic impact of cardiovascular disease differ between patients with or without diabetes. We aimed to explore differences in the prevalence and prognosis of myocardial ischemia by automated quantification of total perfusion deficit (TPD) among patients with and without diabetes.
RESEARCH DESIGN AND METHODS:
Of 20,418 individuals who underwent single-photon emission computed tomography myocardial perfusion imaging, 2,951 patients with diabetes were matched to 2,951 patients without diabetes based on risk factors using propensity score. TPD was categorized as TPD = 0%, 0% < TPD < 1%, 1% ≤ TPD < 5%, 5% ≤ TPD ≤ 10%, and TPD >10%. Major adverse cardiovascular events (MACE) were defined as a composite of all-cause mortality, myocardial infarction, unstable angina, or late revascularization.
RESULTS:
MACE risk was increased in patients with diabetes compared with patients without diabetes at each level of TPD above 0 (P < 0.001 for interaction). In patients with TPD >10%, patients with diabetes had greater than twice the MACE risk compared with patients without diabetes (annualized MACE rate 9.4 [95% CI 6.7-11.6] and 3.9 [95% CI 2.8-5.6], respectively, P < 0.001). Patients with diabetes with even very minimal TPD (0% < TPD < 1%) experienced a higher risk for MACE than those with 0% TPD (hazard ratio 2.05 [95% CI 1.21-3.47], P = 0.007). Patients with diabetes with a TPD of 0.5% had a similar MACE risk as patients without diabetes with a TPD of 8%.
CONCLUSIONS:
For every level of TPD >0%, even a very minimal deficit of 0% < TPD < 1%, the MACE risk was higher in the patients with diabetes compared with patients without diabetes. Patients with diabetes with minimal ischemia had comparable MACE risk as patients without diabetes with significant ischemia.
AuthorsDonghee Han, Alan Rozanski, Heidi Gransar, Tali Sharir, Andrew J Einstein, Mathews B Fish, Terrence D Ruddy, Philipp A Kaufmann, Albert J Sinusas, Edward J Miller, Timothy M Bateman, Sharmila Dorbala, Marcelo Di Carli, Joanna X Liang, Lien-Hsin Hu, Guido Germano, Damini Dey, Daniel S Berman, Piotr J Slomka
JournalDiabetes care (Diabetes Care) Vol. 43 Issue 2 Pg. 453-459 (02 2020) ISSN: 1935-5548 [Electronic] United States
PMID31776140 (Publication Type: Journal Article, Multicenter Study, Observational Study, Research Support, N.I.H., Extramural)
Copyright© 2019 by the American Diabetes Association.
Topics
  • Aged
  • Angina, Unstable (diagnosis, epidemiology)
  • Cohort Studies
  • Coronary Artery Disease (complications, diagnosis, epidemiology)
  • Diabetes Mellitus (diagnosis, epidemiology)
  • Diabetic Angiopathies (diagnosis, epidemiology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (complications, diagnosis, epidemiology)
  • Myocardial Ischemia (complications, diagnosis, epidemiology)
  • Myocardial Perfusion Imaging (methods, statistics & numerical data)
  • Prevalence
  • Prognosis
  • Propensity Score
  • Registries
  • Risk Factors
  • Tomography, Emission-Computed, Single-Photon (methods, statistics & numerical data)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: